Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)

Publikation

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)

Wissenschaftlicher Artikel/Review - 03.05.2016

Wick Wolfgang, Golfinopoulos Vassilis, Frenel Jean-Sebastien, Campone Mario, Ricard Damien, Marosi Christine, Villa Salvador, Weyerbrock Astrid, Hopkins Kirsten, Homicsko Krisztian, Lhermitte Benoit, Pesce Gianfranco, Roth Patrick, Stupp Roger, Gorlia Thierry, Bady Pierre, Platten Michael, van den Bent Martin J, Taphoorn Martin J B, Steuve Jonathan, Brandes Alba A, Hamou Marie-France, Wick Antje, Kosch Markus, Weller Michael, Hegi Monika E

Wick, Wolfgang

Gorlia, Thierry

Bady, Pierre

Platten, Michael

van den Bent, Martin J

Taphoorn, Martin J B

Steuve, Jonathan

Brandes, Alba A

Hamou, Marie-France

Wick, Antje

Kosch, Markus

Weller, Michael

Stupp, Roger

Roth, Patrick

Golfinopoulos, Vassilis

Frenel, Jean-Sebastien

Campone, Mario

Ricard, Damien

Marosi, Christine

Villa, Salvador